Case | HBS Case Collection | 2008
by Vicki L. Sato and Rachel Gordon
Dr. John Mendlein, CEO of Adnexus Therapeutics Inc. (Adnexus), a private biotechnology company, must decide whether to pursue acquisition talks with Bristol-Myers Squibb (BMS) after a successful six-month collaboration or continue with Adnexus' planned IPO.
Keywords: Mergers and Acquisitions; Decision Choices and Conditions; Entrepreneurship; Initial Public Offering; Corporate Strategy; Biotechnology Industry;
Citation:
Sato, Vicki L., and Rachel Gordon. "Adnexus Therapeutics, Inc.: Considering the Exit." Harvard Business School Case 609-015, November 2008.
View Profile »View Publications »
Case | HBS Case Collection | 2012
BMS-Biocon Research Center: Growing a Joint Research Venture in India
Vicki Sato, Sen Chai, Rich Ballenger, Christine Chi, Alexander Down and Ross Leimberg
Keywords: Pharmaceuticals; Global innovation; Research and Development; Biomedical Research; Joint Ventures; India; United States;
Teaching Plan | HBS Case Collection | 2012
The Langer Lab: Commercializing Science (TP)
Vicki L. Sato and Annelena Lobb
Keywords: computers; industry evolution; entrepreneurship; Intellectual capital; patents; R&D; Technology Transfer; Patents; Research and Development; Massachusetts;
Case | HBS Case Collection | 2012 (Revised from original 2011 version)
China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise
Vicki Sato, Christoph Jaeker and Pooja Mehta Solanki
Keywords: Business Growth and Maturation; Globalized Firms and Management; Research; Integration; Health Industry; Pharmaceutical Industry; China;